Judge Blocks Layoffs at U.S. Health Department
By I. Edwards HealthDay Reporter
Medically reviewed by Drugs.com

WEDNESDAY, July 2, 2025 — A federal judge has stopped the Trump administration from implementing more layoffs at the U.S. Department of Health and Human Services (HHS), saying the job cuts likely went against the law.
The decision came Tuesday from U.S. District Judge Melissa DuBose in response to a lawsuit filed by attorneys general from 19 states and the District of Columbia, The Associated Press reported.
DuBose said the layoffs caused “irreparable harm” and were likely “arbitrary and capricious.”
“The executive branch does not have the authority to order, organize, or implement wholesale changes to the structure and function of the agencies created by Congress,” she added in her 58-page order.
Her ruling blocks any more layoffs or changes to the agency’s structure while the lawsuit continues. HHS must report back to the court by July 11.
In a statement, HHS spokesperson Andrew Nixon said, “We stand by our original decision to realign this organization with its core mission and refocus a sprawling bureaucracy that, over time, had become wasteful, inefficient and resistant to change."
Health Secretary Robert F. Kennedy Jr. had already cut more than 10,000 workers in March and merged 28 agencies into 15 as part of the administration’s “Make America Healthy Again” plan, The AP said.
Some layoffs were reversed after public outcry, including CDC cuts that affected workers tracking HIV, hepatitis and other serious diseases.
Tuesday’s court ruling applies to workers in four key areas of HHS: the U.S. Centers for Disease Control and Prevention; the Center for Tobacco Products within the Food and Drug Administration; the Office of Head Start within the Administration for Children and Families and employees of regional offices who work on Head Start matters; and the Office of the Assistant Secretary for Planning and Evaluation, The AP said.
In their lawsuit, state leaders said the cuts stripped away crucial services and pushed unnecessary costs onto states.
DuBose agreed, writing that states lost access to “funds, guidance, research, screenings, compliance oversight, data, and, importantly, the expertise and guidance on which they have long relied.”
At a Senate hearing in May, Kennedy said there was “so much chaos and disorganization” inside HHS, The AP noted. He conceded that mistakes had been made — and that up to 20% of fired workers might be reinstated.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-03 00:00
Read more

- USPSTF: Screen Women of Reproductive Age for Intimate Partner Violence
- Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer
- FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
- Acupuncture Can Make IVF More Comfortable, Study Says
- U.S. Stops Funding for Gavi Global Vaccine Program, Sparking Backlash
- Breast Cancer Incidence Trends Vary by Age
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions